Key model for drug development of inflammatory bowel disease

　 Inflammatory Bowel Disease (IBD) is a collective term for a specific group of chronic intestinal diseases, including Crohn’s disease and ulcerative colitis. IBD is characterized by chronic and recurrent gastrointestinal inflammation, which can increase the risk of colitis-related cancers.
　KCI Biomedical Research Team has established a stable inflammatory bowel disease model to help you deal with the challenges of drug development in the field of enteritis and meet your new drug development requirements.
　 If you have project needs and experience our more professional services, please contact us.

Our Service

Type	Modeling method	Animals
IBD Enteritis model	DSS-induced IBD model	Mouse
	TNBS-induced IBD model	Mouse、rat
	DNBS-induced IBD model	Mouse、rat